Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-dose Chemotherapy With Hematopoietic Stem-cell Rescue for High-risk Breast Cancer: Long-term Follow-up of a Randomized Phase III Study

NCT03087409 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT03087409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03087409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-dose Chemotherapy With Hematopoietic Stem-cell Rescue for High-risk Breast Cancer: Long-term Follow-up of a Randomized Phase III Study
Lead sponsor
University Medical Center Groningen
Phase
Observational
Overall status
Completed
Start date
July 31, 2016
Completion date
July 1, 2018
Enrollment
885 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female